Surmodics Names Chief Marketing Officer

Surmodics Inc., a provider of medical device and in-vitro diagnostic technologies to the healthcare industry, announced that Teri Sides has joined the company as senior vice president and chief marketing officer.
 
“I am thrilled to welcome Teri to our internal team. Teri has been an important contributor to our business, product and clinical strategy since 2011, including being a founding member of our SurVeil, Avess and Sundance drug-coated balloon development programs,” said Gary Maharaj, president and CEO of Surmodics. “Her leadership and strategic marketing expertise will be critical to drive our efforts in developing differentiated products that deliver strong clinical and economic benefits while improving patient outcomes.”
 
Sides is an industry veteran, bringing over 27 years of medtech and healthcare experience. Prior to joining Surmodics, Sides served as founder and CEO of Projectory, a consulting firm that provides strategic marketing services to med tech clients, ranging from startups to global businesses. Prior to Projectory, Sides was the vice president of Marketing and Product Development for Arizant Inc. Acting as the chief architect for product and market growth strategies, Sides led development of industry-leading products, including the world’s first patient warming gown.

Sides has an MBA from the University of Minnesota’s Carlson School of Management. She has more than eight patents granted and several pending.
 
“I look forward to joining the Surmodics team and leveraging our combined expertise to develop a meaningfully differentiated product pipeline,” said Sides. “Surmodics has demonstrated a commitment to innovation. Their development teams and key technology assets combined with the strength of their customer and clinical relationships enable the creation of highly innovative product solutions for vascular disease and in-vitro diagnostics.”
 
As CMO, Sides will be responsible for developing and driving strategic growth initiatives and will be a member of the senior leadership team reporting directly to Maharaj.
 
Surmodics is a global developer of surface modification technologies for intravascular medical devices and a leading provider of chemical components for in-vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address unmet clinical needs for its medical device customers and engineered to the most demanding requirements. This key growth strategy leverages the combination of the company’s expertise in proprietary surface technologies, along with enhanced device design, development and manufacturing capabilities. The company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minn.